# Douglas Elliman Inc.: financial statements, quarterly

DOUG · NYSE · CIK 1878897 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/doug.md) · [Financials](/companies/doug/financials.md) · [Filings](/companies/doug/filings.md) · [Insiders](/companies/doug/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/doug/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [252](/filings/0001878897-24-000055.md) | [214 d](/filings/0001878897-26-000007.md) | [200](/filings/0001878897-25-000040.md) | [286](/filings/0001878897-25-000050.md) | [266](/filings/0001878897-25-000067.md) | [243 d](/filings/0001878897-26-000007.md) | [253](/filings/0001878897-26-000031.md) | [271](/filings/0001878897-26-000044.md) | [263](/filings/0001878897-25-000067.md) | [245 d](/filings/0001878897-26-000007.md) | [214](/filings/0001878897-26-000031.md) | [283](/filings/0001878897-26-000044.md) |
| Operating income | $m | [(8.8)](/filings/0001878897-24-000055.md) | [(23.6) d](/filings/0001878897-26-000007.md) | [(41.5)](/filings/0001878897-25-000040.md) | [(3.7)](/filings/0001878897-25-000050.md) | [(7.4)](/filings/0001878897-25-000067.md) | [(16.3) d](/filings/0001878897-26-000007.md) | [(5.3)](/filings/0001878897-26-000031.md) | [(5.5)](/filings/0001878897-26-000044.md) | [(10.7)](/filings/0001878897-25-000067.md) | [67.0 d](/filings/0001878897-26-000007.md) | [(17.5)](/filings/0001878897-26-000031.md) | [(3.4)](/filings/0001878897-26-000044.md) |
| Interest expense | $m | [0.0](/filings/0001878897-24-000055.md) | [0.0 d](/filings/0001878897-26-000007.md) | [0.0](/filings/0001878897-25-000040.md) | [0.0](/filings/0001878897-25-000050.md) | [1.5](/filings/0001878897-25-000067.md) | [1.5 d](/filings/0001878897-26-000007.md) | [1.5](/filings/0001878897-26-000031.md) | [1.5](/filings/0001878897-26-000044.md) | [1.6](/filings/0001878897-25-000067.md) | [0.4 d](/filings/0001878897-26-000007.md) | [0.0](/filings/0001878897-26-000031.md) | [0.0](/filings/0001878897-26-000044.md) |
| Income tax | $m | [(1.9)](/filings/0001878897-24-000055.md) | [(6.5) d](/filings/0001878897-26-000007.md) | [1.2](/filings/0001878897-25-000040.md) | [0.2](/filings/0001878897-25-000050.md) | [0.0](/filings/0001878897-25-000067.md) | [(0.3) d](/filings/0001878897-26-000007.md) | [0.0](/filings/0001878897-26-000031.md) | [0.0](/filings/0001878897-26-000044.md) | [0.0](/filings/0001878897-25-000067.md) | [3.5 d](/filings/0001878897-26-000007.md) | [0.0](/filings/0001878897-26-000031.md) | [0.0](/filings/0001878897-26-000044.md) |
| Net income | $m | [(4.9)](/filings/0001878897-24-000055.md) | [(14.8) d](/filings/0001878897-26-000007.md) | [(41.5)](/filings/0001878897-25-000040.md) | [(1.7)](/filings/0001878897-25-000050.md) | [(27.2)](/filings/0001878897-25-000067.md) | [(6.0) d](/filings/0001878897-26-000007.md) | [(6.0)](/filings/0001878897-26-000031.md) | [(22.7)](/filings/0001878897-26-000044.md) | [(24.7)](/filings/0001878897-25-000067.md) | [68.6 d](/filings/0001878897-26-000007.md) | [(16.3)](/filings/0001878897-26-000031.md) | [(2.7)](/filings/0001878897-26-000044.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001878897-24-000055.md) | not reported | [(0.50)](/filings/0001878897-25-000040.md) | [(0.02)](/filings/0001878897-25-000050.md) | [(0.33)](/filings/0001878897-25-000067.md) | not reported | [(0.07)](/filings/0001878897-26-000031.md) | [(0.27)](/filings/0001878897-26-000044.md) | [(0.29)](/filings/0001878897-25-000067.md) | not reported | [(0.19)](/filings/0001878897-26-000031.md) | [(0.03)](/filings/0001878897-26-000044.md) |
| Basic EPS | $ per share | [(0.06)](/filings/0001878897-24-000055.md) | not reported | [(0.50)](/filings/0001878897-25-000040.md) | [(0.02)](/filings/0001878897-25-000050.md) | [(0.33)](/filings/0001878897-25-000067.md) | not reported | [(0.07)](/filings/0001878897-26-000031.md) | [(0.27)](/filings/0001878897-26-000044.md) | [(0.29)](/filings/0001878897-25-000067.md) | not reported | [(0.19)](/filings/0001878897-26-000031.md) | [(0.03)](/filings/0001878897-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [126](/filings/0001878897-23-000054.md) | [120](/filings/0001878897-26-000007.md) | [91.5](/filings/0001878897-24-000018.md) | [92.9](/filings/0001878897-24-000031.md) | [151](/filings/0001878897-24-000055.md) | [136](/filings/0001878897-26-000007.md) | [137](/filings/0001878897-25-000040.md) | [136](/filings/0001878897-25-000050.md) | [143](/filings/0001878897-25-000067.md) | [116](/filings/0001878897-26-000044.md) | [96.0](/filings/0001878897-26-000031.md) | [105](/filings/0001878897-26-000044.md) |
| Current assets | $m | [197](/filings/0001878897-23-000054.md) | [181](/filings/0001878897-25-000009.md) | [155](/filings/0001878897-24-000018.md) | [161](/filings/0001878897-24-000031.md) | [206](/filings/0001878897-24-000055.md) | [196](/filings/0001878897-26-000007.md) | [196](/filings/0001878897-25-000040.md) | [192](/filings/0001878897-25-000050.md) | [193](/filings/0001878897-25-000067.md) | [161](/filings/0001878897-26-000044.md) | [151](/filings/0001878897-26-000031.md) | [160](/filings/0001878897-26-000044.md) |
| Total assets | $m | [511](/filings/0001878897-23-000054.md) | [493](/filings/0001878897-26-000007.md) | [461](/filings/0001878897-24-000018.md) | [464](/filings/0001878897-24-000031.md) | [503](/filings/0001878897-24-000055.md) | [494](/filings/0001878897-26-000007.md) | [494](/filings/0001878897-25-000040.md) | [489](/filings/0001878897-25-000050.md) | [481](/filings/0001878897-25-000067.md) | [444](/filings/0001878897-26-000044.md) | [435](/filings/0001878897-26-000031.md) | [444](/filings/0001878897-26-000044.md) |
| Current liabilities | $m | [93.0](/filings/0001878897-23-000054.md) | [97.2](/filings/0001878897-25-000009.md) | [92.5](/filings/0001878897-24-000018.md) | [90.9](/filings/0001878897-24-000031.md) | [89.7](/filings/0001878897-24-000055.md) | [92.2](/filings/0001878897-26-000007.md) | [101](/filings/0001878897-25-000040.md) | [96.9](/filings/0001878897-25-000050.md) | [101](/filings/0001878897-25-000067.md) | [98.7](/filings/0001878897-26-000044.md) | [102](/filings/0001878897-26-000031.md) | [105](/filings/0001878897-26-000044.md) |
| Total liabilities | $m | [263](/filings/0001878897-23-000054.md) | [259](/filings/0001878897-25-000009.md) | [265](/filings/0001878897-24-000018.md) | [266](/filings/0001878897-24-000031.md) | [329](/filings/0001878897-24-000055.md) | [331](/filings/0001878897-26-000007.md) | [336](/filings/0001878897-25-000040.md) | [351](/filings/0001878897-25-000050.md) | [366](/filings/0001878897-25-000067.md) | [261](/filings/0001878897-26-000044.md) | [267](/filings/0001878897-26-000031.md) | [277](/filings/0001878897-26-000044.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001878897-25-000009.md) | not reported | not reported | [32.1](/filings/0001878897-24-000055.md) | [32.7](/filings/0001878897-26-000007.md) | [33.3](/filings/0001878897-25-000040.md) | [34.0](/filings/0001878897-25-000050.md) | [34.7](/filings/0001878897-25-000067.md) | [0.0](/filings/0001878897-26-000007.md) | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [247](/filings/0001878897-23-000054.md) | [233](/filings/0001878897-25-000009.md) | [195](/filings/0001878897-24-000018.md) | [197](/filings/0001878897-24-000031.md) | [174](/filings/0001878897-24-000055.md) | [162](/filings/0001878897-26-000007.md) | [158](/filings/0001878897-25-000040.md) | [138](/filings/0001878897-25-000050.md) | [115](/filings/0001878897-25-000067.md) | [184](/filings/0001878897-26-000044.md) | [168](/filings/0001878897-26-000031.md) | [167](/filings/0001878897-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.6) d](/filings/0001878897-24-000055.md) | [(2.6) d](/filings/0001878897-26-000007.md) | [(27.3)](/filings/0001878897-25-000040.md) | [1.3 d](/filings/0001878897-25-000050.md) | [9.0 d](/filings/0001878897-25-000067.md) | [(9.0) d](/filings/0001878897-26-000007.md) | [(5.6)](/filings/0001878897-26-000031.md) | [0.6 d](/filings/0001878897-26-000044.md) | [5.5 d](/filings/0001878897-25-000067.md) | [(14.4) d](/filings/0001878897-26-000007.md) | [(19.3)](/filings/0001878897-26-000031.md) | [11.6 d](/filings/0001878897-26-000044.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001878897-24-000055.md) | [0.8 d](/filings/0001878897-26-000007.md) | [2.1](/filings/0001878897-25-000040.md) | [0.9 d](/filings/0001878897-25-000050.md) | [1.3 d](/filings/0001878897-25-000067.md) | [1.3 d](/filings/0001878897-26-000007.md) | [1.0](/filings/0001878897-26-000031.md) | [1.2 d](/filings/0001878897-26-000044.md) | [0.8 d](/filings/0001878897-25-000067.md) | [0.3 d](/filings/0001878897-26-000007.md) | [0.3](/filings/0001878897-26-000031.md) | [0.7 d](/filings/0001878897-26-000044.md) |
| Dividends paid | $m | [0.0 d](/filings/0001878897-24-000055.md) | [0.0 d](/filings/0001878897-26-000007.md) | [0.0](/filings/0001878897-24-000018.md) | [0.0 d](/filings/0001878897-24-000031.md) | [0.0 d](/filings/0001878897-24-000055.md) | [0.0 d](/filings/0001878897-26-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.6](/filings/0001878897-23-000054.md) | [82.2](/filings/0001878897-24-000018.md) | [82.2](/filings/0001878897-24-000031.md) | [82.2](/filings/0001878897-24-000055.md) | [83.3](/filings/0001878897-25-000040.md) | [83.3](/filings/0001878897-25-000050.md) | [83.5](/filings/0001878897-25-000067.md) | [84.4](/filings/0001878897-26-000031.md) | [84.5](/filings/0001878897-26-000044.md) | [84.6](/filings/0001878897-25-000067.md) | [85.6](/filings/0001878897-26-000031.md) | [85.7](/filings/0001878897-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 90,890,473 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001878897-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.